Jedd Levine
Overview
Explore the profile of Jedd Levine including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
5
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schwarzer A, Oliveira M, Kleppa M, Slattery S, Anantha A, Cooper A, et al.
Mol Cancer Ther
. 2023 Aug;
22(11):1290-1303.
PMID: 37643767
DLBCL are aggressive, rapidly proliferating tumors that critically depend on the ATF4-mediated integrated stress response (ISR) to adapt to stress caused by uncontrolled growth, such as hypoxia, amino acid deprivation,...
2.
Hunter E, Salter M, Powell R, Dring A, Naithani T, Chatziioannou M, et al.
Cancers (Basel)
. 2023 Jun;
15(10).
PMID: 37345033
Background: Unprecedented advantages in cancer treatment with immune checkpoint inhibitors (ICIs) remain limited to only a subset of patients. Systemic analyses of the regulatory 3D genome architecture linked to individual...
3.
Cooper A, Ciblat S, Shipps G, Levine J, Kostura M, Oza V, et al.
Bioorg Med Chem Lett
. 2018 Feb;
28(5):985.
PMID: 29433931
No abstract available.
4.
Cooper A, Ciblat S, Shipps G, Levine J, Kostura M, Oza V, et al.
Bioorg Med Chem Lett
. 2017 Aug;
27(18):4471-4477.
PMID: 28844391
A class of substituted 1-thiazol-2-yl-N-3-methyl-1H-pyrozole-5-carboxylic acid derivatives was found to have potent anti-proliferative activity against a broad range of tumor cell lines. A compound from this class (14) was profiled...